IL-12 in autoimmunity

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 4-13

  Caspi, Rachel R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR;

AUTOIMMUNITY; CELLULAR IMMUNITY; HUMAN; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031825805     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4540     Document Type: Review

References (117)

1. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827-845.
2. Merberg D. M., Wolf S. F., Clark S. C. Sequence similarity between NKSF and the IL-6/G-CSF family [letter]. Immunol. Today. 13:1992;77-78.
3. Gillessen S., Carvajal D., Ling P., Podlaski F. J., Stremlo D. L., Familletti P. C., Gubler U., Presky D. H., Stern A. S., Gately M. K. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:1995;200-206.
4. Heinzel F. P., Hujer A. M., Ahmed F. N., Rerko R. M. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158:1997;4381-4388.
5. Presky D. H., Yang H., Minetti L. J., Chua A. O., Nabavi N., Wu C. Y., Gately M. K., Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA. 93:1996;14002-14007.
6. Wu C. Y., Ferrante J., Gately M. K., Magram J. Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice-IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1997;1658-1665.
7. Szabo S. J., Dighe A. S., Gubler U., Murphy K. M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
8. Ma X., D'Andrea A., Kubin M., Aste-Amezaga M., Sartori A., Monteiro J., Showe L., Wysocka M., Trinchieri G. Production of interleukin-12. Res. Immunol. 146:1995;432-438.
9. Guéry J. C., Ria F., Galbiati F., Adorini L. Normal B cells fail to secrete interleukin-12. Eur. J. Immunol. 27:1997;1632-1639.
10. D'Andrea A., Rengaraju M., Valiante N. M., Chehimi J., Kubin M., Aste M., Chan S. H., Kobayashi M., Young D., Nickbarg E. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
11. Cassatella M. A., Meda L., Gasperini S., D'Andrea A., Ma X., Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1995;1-5.
12. Yawalkar N., Limat A., Brand C. U., Braathen L. R. Constitutive expression of both subunits of interleukin-12 in human keratinocytes. J. Invest. Dermatol. 106:1996;80-83.
13. Aragane Y., Riemann H., Bhardwaj R. S., Schwarz A., Sawada Y., Yamada H., Luger T. A., Kubin M., Trinchieri G., Schwarz T. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J. Immunol. 153:1994;5366-5372.
14. Goodman R. E., Nestle F., Naidu Y. M., Green J. M., Thompson C. B., Nickoloff B. J., Turka L. A. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma. J. Immunol. 152:1994;5189-5198.
15. Kang K., Kubin M., Cooper K. D., Lessin S. R., Trinchieri G., Rook A. H. IL-12 synthesis by human Langerhans cells. J. Immunol. 156:1996;1402-1407.
16. Chan S. H., Perussia B., Gupta J. W., Kobayashi M., Pospisil M., Young H. A., Wolf S. F., Young D., Clark S. C., Trinchieri G. Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
17. Gately M. K., Wolitzky A. G., Quinn P. M., Chizzonite R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143:1992;127-142.
18. Schmitt E., Rude E., Germann T. The immunostimulatory function of IL-12 in T-helper cell development and its regulation by TGF-beta, IFN-gamma and IL-4. Chem. Immunol. 68:1997;70-85.
19. Orange J. S., Wang B., Terhorst C., Biron C. A. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1995;1045-1056.
20. Ozmen L., Aguet M., Trinchieri G., Garotta G. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J. Virol. 69:1995;8147-8150.
21. McKnight A. J., Zimmer G. J., Fogelman I., Wolf S. F., Abbas A. K. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:1994;2172-2179.
22. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
23. Ma X., Chow J. M., Gri G., Carra G., Gerosa F., Wolf S. F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183:1996;147-157.
24. Klinman D. M., Yi A. K., Beaucage S. L., Conover J., Krieg A. M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
25. Gazzinelli R. T., Camargo M. M., Almeida I. C., Morita Y. S., Giraldo M., Acosta-Serrano A., Hieny S., Englund P. T., Ferguson M. A., Travassos L. R., Sher A. Identification and characterization of protozoan products that trigger the synthesis of IL-12 by inflammatory macrophages. Chem. Immunol. 68:1997;136-152.
26. Sousa C. R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R. N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [see comments]. J. Exp. Med. 186:1997;1819-1829.
27. Takenaka H., Maruo S., Yamamoto N., Wysocka M., Ono S., Kobayashi M., Yagita H., Okumura K., Hamaoka T., Trinchieri G., Fujiwara H. Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4. J. Leukocyte Biol. 61:1997;80-87.
28. DeKruyff R. H., Gieni R. S., Umetsu D. T. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J. Immunol. 158:1997;359-366.
29. Scharton-Kersten T. M., Wynn T. A., Denkers E. Y., Bala S., Grunvald E., Hieny S., Gazzinelli R. T., Sher A. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:1996;4045-4054.
30. Heinzel F. P., Rerko R. M., Ahmed F., Hujer A. M. IFN-gamma-independent production of IL-12 during murine endotoxemia. J. Immunol. 157:1996;4521-4528.
31. Reiner S. L., Locksley R. M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
32. O'Garra A., Murphy K. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:1994;458-466.
33. Kennedy M. K., Picha K. S., Fanslow W. C., Grabstein K. H., Alderson M. R., Clifford K. N., Chin W. A., Mohler K. M. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:1996;370-378.
34. Grewal I. S., Flavell R. A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:1996;85-106.
35. Grewal I. S., Foellmer H. G., Grewal K. D., Xu J., Hardardottir F., Baron J. L., Janeway C. A. Jr., Flavell R. A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864-1867.
36. Durie F. H., Fava R. A., Foy T. M., Aruffo A., Ledbetter J. A., Noelle R. J. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1993;1328-1330.
37. Whitcup S. M., Chan C. C., Gery I., Kalled S. L., Wiggert B., Magone M. T. Anti-CD40 Ligand (CD40L) antibody inhibits experimental autoimmune uveitis (EAU). Invest. Ophthalmol. Vis. Sci. 39:1998;S866.
38. Trinchieri G., Scott P. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions [editorial]. Res. Immunol. 146:1995;423-431.
39. Ryffel B. Interleukin-12: Role of interferon-gamma in IL-12 adverse effects [see comments]. Clin. Immunol. Immunopathol. 83:1997;18-20.
40. Car B. D., Eng V. M., Schnyder B., LeHir M., Shakhov A. N., Woerly G., Huang S., Aguet M., Anderson T. D., Ryffel B. Role of interferon-gamma in interleukin 12-induced pathology in mice [see comments]. Am. J. Pathol. 147:1995;1693-1707.
41. D'Andrea A., Ma X., Aste-Amezaga M., Paganin C., Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 181:1995;537-546.
42. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1993;1041-1048.
43. Ma X., Aste-Amezaga M., Trinchieri G. Regulation of interleukin-12 production. Ann. N. Y. Acad. Sci. 795:1996;13-25.
44. Ma X., Aste-Amezaga M., Gri G., Gerosa F., Trinchieri G. Immunomodulatory functions and molecular regulation of IL-12. Chem. Immunol. 68:1997;1-22.
45. Morris S. C., Madden K. B., Adamovicz J. J., Gause W. C., Hubbard B. R., Gately M. K., Finkelman F. D. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1994;1047-1056.
46. De Smedt T., Van Mechelen M., De Becker G., Urbain J., Leo O., Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1997;1229-1235.
47. Kelsall B. L., Stuber E., Neurath M., Strober W. Interleukin-12 production by dendritic cells. Ann. N. Y. Acad. Sci. 795:1996;116-126.
48. Windhagen A., Anderson D. E., Carrizosa A., Williams R. E., Hafler D. A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J. Immunol. 157:1996;1127-1131.
49. Trembleau S., Germann T., Gately M. K., Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today. 16:1995;383-386.
50. Adorini L., Gregori S., Magram J., Trembleau S. The role of IL-12 in the pathogenesis of Th1 cell-mediated autoimmune diseases. Ann. N. Y. Acad. Sci. 795:1996;208-215.
51. Trembleau S., Penna G., Bosi E., Mortara A., Gately M. K., Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:1995;817-821.
52. Leonard J. P., Waldburger K. E., Schaub R. G., Smith T., Hewson A. K., Cuzner M. L., Goldman S. J. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit. Rev. Immunol. 17:1997;545-553.
53. Germann T., Szeliga J., Hess H., Storkel S., Podlaski F. J., Gately M. K., Schmitt E., Rude E. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA. 92:1995;4823-4827.
54. McIntyre K. W., Shuster D. J., Gillooly K. M., Warrier R. R., Connaughton S. E., Hall L. B., Arp L. H., Gately M. K., Magram J. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26:1996;2933-2938.
55. Yokoi H., Kato K., Kezuka T., Sakai J., Usui M., Yagita H., Okumura K. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur. J. Immunol. 27:1997;641-646.
56. Strober W., Kelsall B., Fuss I., Marth T., Ludviksson B., Ehrhardt R., Neurath M. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol. Today. 18:1997;61-64.
57. Rennick D. M., Fort M. M., Davidson N. J. Studies with IL-10-/-mice: An overview. J Leukocyte Biol. 61:1997;389-396.
58. Tarrant, T. K. Silver, P. B. Chan, C. C. Caspi, R. R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis, J. Immunol.
59. Leonard J. P., Waldburger K. E., Goldman S. J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
60. Jones L. S., Rizzo L. V., Agarwal R. K., Tarrant T. K., Chan C. C., Wiggert B., Caspi R. R. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158:1997;5997-6005.
61. Ferber I. A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C. G. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
62. Güler M. L., Jacobson N. G., Gubler U., Murphy K. M. T cell genetic background determines maintenance of IL-12 signaling-Effects on BALB/c and B10. J. Immunol. 159:1997;1767-1774.
63. Gorham J. D., Guler M. L., Murphy K. M. Genetic control of interleukin 12 responsiveness: Implications for disease pathogenesis. J. Mol. Med. 75:1997;502-511.
64. Romagnani S., Parronchi P., D'Elios M. M., Romagnani P., Annunziato F., Piccinni M. P., Manetti R., Sampognaro S., Mavilia C., De Carli M., Maggi E., Del Prete G. F. An update on human Th1 and Th2 cells. Int. Arch. Allergy Immunol. 113:1997;153-156.
65. Nakajima A., Hirose S., Yagita H., Okumura K. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158:1997;1466-1472.
66. Fan X., Oertli B., Wuthrich R. P. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(1pr) mice with renal injury. Kidney Int. 51:1997;79-86.
67. Huang F. P., Feng G. J., Lindop G., Stott D. I., Liew F. Y. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRLMP-1pr1pr mice. J. Exp. Med. 183:1996;1447-1459.
68. Metzger D. W., McNutt R. M., Collins J. T., Buchanan J. M., Van Cleave V. H., Dunnick W. A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 27:1997;1958-1965.
69. Houssiau F. A., Mascart-Lemone F., Stevens M., Libin M., Devogelaer J. P., Goldman M., Renauld J. C. IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clin. Exp. Immunol. 108:1997;375-380.
70. Roman M., Martin-Orozco E., Goodman S., Nguyen M. D., Sato Y., Ronaghy A., Kornbluth R. S., Richman D. D., Carson D. A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Med. 3:1997;849-854.
71. Segal B. M., Klinman D. M., Shevach E. M. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158:1997;5087-5090.
72. Aliberti J. C., Cardoso M. A., Martins G. A., Gazzinelli R. T., Vieira L. Q., Silva J. S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1996;1961-1967.
73. Cunha-Neto E., Coelho V., Guilherme L., Fiorelli A., Stolf N., Kalil J. Autoimmunity in Chagas' disease: Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J. Clin. Invest. 98:1996;1709-1712.
74. Cunha-Neto E., Rizzo L. V., Albuquerque F., Abel L., Guilherme L., Bocchi E., Bacal F., Carrara D., Ianni G., Mady C., Kalil J. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Brazil. J. Med. Biol. Res. 31:1998;133-137.
75. Davies J. M. Molecular mimicry: Can epitope mimicry induce autoimmune disease. Immunol. Cell Biol. 75:1997;113-126.
76. Baum H., Staines N. A. MHC-derived peptides and the CD4+ T-cell repertoire: Implications for autoimmune disease. Cytokines Cell Mol. Ther. 3:1997;115-125.
77. Segal B. M., Shevach E. M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:1996;771-775.
78. Constantinescu C. S., Frei K., Wysocka M., Trinchieri G., Malipiero U., Rostami A., Fontana A. Astrocytes and microglia produce interleukin-12 p40. Ann. N. Y. Acad. Sci. 795:1996;328-333.
79. Aloisi F., Penna G., Cerase J., Menendez Iglesias B., Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159:1997;1604-1612.
80. Rizzo L. V., Silver P., Wiggert B., Hakim F., Gazzinelli R. T., Chan C. C., Caspi R. R. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10. J. Immunol. 156:1996;1654-1660.
81. Krakowski M. L., Owens T. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2840-2847.
82. O'Hara R. M. Jr., Henderson S. L., Nagelin A. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann. N. Y. Acad. Sci. 795:1996;241-249.
83. Joosten L. A. B., Lubberts E., Helsen M. M. A., Van den Berg W. B. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J. Immunol. 159:1997;4094-4102.
84. Hess H., Gately M. K., Rude E., Schmitt E., Szeliga J., Germann T. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur. J. Immunol. 26:1996;187-191.
85. Shu U., Kiniwa M., Wu C. Y., Maliszewski C., Vezzio N., Hakimi J., Gately M., Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1995;1125-1128.
86. Day M. J., Tse A. G., Puklavec M., Simmonds S. J., Mason D. W. Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats. J. Exp. Med. 175:1992;655-659.
87. Macaulay A. E., DeKruyff R. H., Goodnow C. C., Umetsu D. T. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. J. Immunol. 158:1997;4171-4179.
88. Saoudi A., Simmonds S., Huitinga I., Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: Evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells [see comments]. J. Exp. Med. 182:1995;335-344.
89. Zambidis E. T., Kurup A., Scott D. W. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol. Med. 3:1997;212-224.
90. Laman J. D., Claassen E., Noelle R. J. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:1996;59-108.
91. Samoilova E. B., Horton J. L., Zhang H., Chen Y. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J. Mol. Med. 75:1997;603-608.
92. Koshy M., Berger D., Crow M. K. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:1996;826-837.
93. Blossom S., Chu E. B., Weigle W. O., Gilbert K. M. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J. Immunol. 159:1997;4580-4586.
94. Persson S., Mikulowska A., Narula S., O'Garra A., Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand. J. Immunol. 44:1996;607-614.
95. Bai X. F., Zhu J., Zhang G. X., Kaponides G., Hojeberg B., van der Meide P. H., Link H. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin. Immunol. Immunopathol. 83:1997;117-126.
96. Mignon-Godefroy K., Rott O., Brazillet M. P., Charreire J. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): Evidence for IL-10-enhanced cell death in EAT. J. Immunol. 154:1995;6634-6643.
97. Pennline K. J., Roque-Gaffney E., Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:1994;169-175.
98. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
99. Rizzo L. V., Xu H., Chan C. C., Wiggert B., Caspi R. R. IL-10 has a protective role in experimental autoimmune uveitis. Int. Immunol. 1998.
100. Wogensen L., Lee M. S., Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 179:1994;1379-1384.
101. Lee M. S., Mueller R., Wicker L. S., Peterson L. B., Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:1996;2663-2668.
102. Ramanathan S., de Kozak Y., Saoudi A., Goureau O., Van der Meide P. H., Druet P., Bellon B. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J. Immunol. 157:1996;2209-2215.
103. Nagelkerken L., Blauw B., Tielemans M. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9:1997;1243-1251.
104. Johns L. D., Flanders K. C., Ranges G. E., Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol. 147:1991;1792-1796.
105. Racke M. K., Dhib-Jalbut S., Cannella B., Albert P. S., Raine C. S., McFarlin D. E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J. Immunol. 146:1991;3012-3017.
106. Santambrogio L., Hochwald G. M., Saxena B., Leu C. H., Martz J. E., Carlino J. A., Ruddle N. H., Palladino M. A., Gold L. I., Thorbecke G. J. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis: Antagonism between TGF-beta and tumor necrosis factor. J. Immunol. 151:1993;1116-1127.
107. Weiner H. L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
108. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:1993;770-774.
109. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
110. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rude E., Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:1993;2202-2208.
111. Gately M. K., Carvajal D. M., Connaughton S. E., Gillessen S., Warrier R. R., Kolinsky K. D., Wilkinson V. L., Dwyer C. M., Higgins G. F. Jr., Podlaski F. J., Faherty D. A., Familletti P. C., Stern A. S., Presky D. H. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. N. Y. Acad. Sci. 795:1996;1-12.
112. Adorini L., Aloisi F., Galbiati F., Gately M. K., Gregori S., Penna G., Ria F., Smiroldo S., Trembleau S. Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases. Chem. Immunol. 68:1997;175-197.
113. Kaplan M. H., Sun Y. L., Hoey T., Grusby M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:1996;174-177.
114. Szabo S. J., Jacobson N. G., Dighe A. S., Gubler U., Murphy K. M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2:1995;665-675.
115. Hilkens C. M., Messer G., Tesselaar K., van Rietschoten A. G., Kapsenberg M. L., Wierenga E. A. Lack of IL-12 signaling in human allergen-specific Th2 cells. J. Immunol. 157:1996;4316-4321.
116. Perez V. L., Lederer J. A., Lichtman A. H., Abbas A. K. Stability of Th1 and Th2 populations. Int. Immunol. 7:1995;869-875.
117. Murphy E., Shibuya K., Hosken N., Openshaw P., Maino V., Davis K., Murphy K., O'Garra A. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:1996;901-913.